NasdaqGS - Nasdaq Real Time Price USD

Akoya Biosciences, Inc. (AKYA)

1.2550
-0.0450
(-3.46%)
As of 1:34:46 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
79,961
81,672
96,633
74,859
54,917
Cost of Revenue
30,591
33,794
40,328
31,469
20,699
Gross Profit
49,370
47,878
56,305
43,390
34,218
Operating Expense
86,782
89,062
112,337
109,598
71,443
Operating Income
-37,412
-41,184
-56,032
-66,208
-37,225
Net Non Operating Interest Income Expense
-8,427
-7,923
-5,272
-3,777
-3,024
Other Income Expense
-1,563
-6,112
-1,979
-533
-2,826
Pretax Income
-47,402
-55,219
-63,283
-70,518
-43,075
Tax Provision
131
146
40
123
-140
Net Income Common Stockholders
-47,533
-55,365
-63,323
-70,641
-44,370
Diluted NI Available to Com Stockholders
-47,533
-55,365
-63,323
-70,641
-44,370
Basic EPS
-0.96
--
-1.43
-1.87
-1.65
Diluted EPS
-0.96
--
-1.43
-1.87
-1.65
Basic Average Shares
49,537.6210
--
44,434.5700
37,746.9150
26,896.9760
Diluted Average Shares
49,537.6210
--
44,434.5700
37,746.9150
26,896.9760
Total Operating Income as Reported
-38,557
-46,730
-57,668
-66,106
-39,298
Total Expenses
117,373
122,856
152,665
141,067
92,142
Net Income from Continuing & Discontinued Operation
-47,533
-55,365
-63,323
-70,641
-42,935
Normalized Income
-46,628.4500
-50,983.6600
-62,030.5600
-70,721.5800
-40,617.4400
Interest Income
1,882
2,506
3,489
777
91
Interest Expense
10,309
10,429
8,761
4,554
3,115
Net Interest Income
-8,427
-7,923
-5,272
-3,777
-3,024
EBIT
-37,093
-44,790
-54,522
-65,964
-39,960
EBITDA
-29,692
-37,136
-45,632
-58,815
-35,168
Reconciled Cost of Revenue
30,591
33,794
40,328
31,054
20,633
Reconciled Depreciation
7,401
7,654
8,890
7,149
4,792
Net Income from Continuing Operation Net Minority Interest
-47,533
-55,365
-63,323
-70,641
-42,935
Total Unusual Items Excluding Goodwill
-1,145
-5,546
-1,636
102
-2,325
Total Unusual Items
-1,145
-5,546
-1,636
102
-2,325
Normalized EBITDA
-28,547
-31,590
-43,996
-58,917
-32,843
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0
Tax Effect of Unusual Items
-240.4500
-1,164.6600
-343.5600
21.4200
-7.4400
12/31/2021 - 4/16/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EKSO Ekso Bionics Holdings, Inc.
0.2775
-0.39%
 
LUCY Innovative Eyewear, Inc.
2.8799
+3.59%
 
POAI Predictive Oncology Inc.
1.0000
+2.04%
 
STSS Sharps Technology, Inc.
4.0000
+1.52%
 
HBIO Harvard Bioscience, Inc.
0.3228
-2.24%
 
GCTK GlucoTrack, Inc.
0.1303
-1.89%
 
OSUR OraSure Technologies, Inc.
2.5050
-2.34%
 
MHUA Meihua International Medical Technologies Co., Ltd.
0.3905
-1.11%
 
WRBY Warby Parker Inc.
20.13
-0.20%
 
MBOT Microbot Medical Inc.
2.6350
+2.53%